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Neurexins and neuroligins play an essential role in
synapse function, and their alterations are linked to
autistic spectrum disorder. Interactions between neu-
rexins and neuroligins regulate inhibitory and excit-
atory synaptogenesis in vitro through a ‘‘splice-insert
signaling code.’’ In particular, neurexin 1b carrying an
alternative splice insert at site SS#4 interacts with
neuroligin 2 (found predominantly at inhibitory synap-
ses) but much less so with other neuroligins (those
carrying an insert at site B and prevalent at excitatory
synapses). The structure of neurexin 1b+SS#4 reveals
dramatic rearrangements to the ‘‘hypervariable sur-
face,’’ the binding site for neuroligins. The splice
insert protrudes as a long helix into space, triggers
conversion of loop b10-b11 into a helix rearranging
the binding site for neuroligins, and rearranges the
Ca2+-binding site required for ligand binding, increas-
ing its affinity. Our structures reveal the mechanism
by which neurexin 1b isoforms acquire neuroligin
splice isoform selectivity.
INTRODUCTION
Neurexins are cell-surface adhesion molecules found at synap-
ses, located predominantly on presynaptic membranes (re-
viewed in Craig and Kang, 2007; Ushkaryov et al., 1992; Graf
et al., 2004; Missler et al., 2003; Dean et al., 2003; and Taniguchi
et al., 2007). The extracellular domains of a-neurexins consist of
six LNS/LG (laminin, neurexin, sex hormone binding globulin/
laminin G) domains interspersed by three EGF-like repeats.
The ectodomains of b-neurexins are made up of only a short
b-neurexin-specific sequence and a single LNS/LG domain that
is identical in amino acid sequence to its a-neurexin counterpart,
the sixth LNS/LG domain. The repertoire of neurexins is dramat-
ically increased by alternative splicing of mRNA transcripts at
five positions in a-neurexins and two positions in b-neurexins,
modifying regions that encode the extracellular domain to pro-
duce more than 2000 possible neurexin isoforms (Rowen et al.,
2002; Tabuchi and Su¨dhof, 2002). As a consequence of splicing,
highly conserved polypeptide splice inserts reaching 30 amino
acids in length incorporate at highly conserved positions in the422 Structure 16, 422–431, March 2008 ª2008 Elsevier Ltd All righLNS/LG domains (splice site SS#2 in n1a_L2, splice site SS#3
in n1a_L4, and splice site SS#4 in n1b_L/n1a_L6) (Figure 1A)
(Rowen et al., 2002; Tabuchi and Su¨dhof, 2002). SS#2, SS#3,
and SS#4 map to loops that surround a Ca2+-binding site and
form the ‘‘hypervariable surface’’ (Figure 1B). Single neurexin
LNS/LG domains suffice to bind protein ligands; binding is typi-
cally Ca2+ dependent and regulated through the presence (or ab-
sence) of splice inserts. Protein partners have been identified for
different neurexin LNS/LG domains including: the postsynaptic
adhesion molecules neuroligins (mediated by n1b_L/n1a_L6),
the spider venom toxin a-latrotoxin (mediated by n1b_L/
n1a_L6), and the extracellular matrix protein a-dystroglycan
(mediated by n1a_L2 as well as n1b_L/n1a_L6) (Ichtchenko
et al., 1995, 1996; Sugita et al., 1999, 2001; Boucard et al.,
2005; Chih et al., 2006; Graf et al., 2006). The protein partner
interaction sites likely coincide with the hypervariable surfaces
on neurexin LNS/LG domains as has indeed been established
for neuroligin 1 and neuroligin 4 binding to neurexin 1b (Figure 1B)
(Rudenko et al., 2001; Graf et al., 2006; Arac¸ et al., 2007; Chen
et al., 2007; Fabrichny et al., 2007). Given the diversity, modular
domain structure, and multiplicity of protein partners, neurexins
are well positioned to fine tune synaptic protein networks
through their protein:protein interactions.
The best studied neurexin:protein interaction, the neurexin
1b-neuroligin trans-synaptic bridge, spans the synaptic cleft
and plays a key role in synapse maintenance and function (Craig
and Kang, 2007). Neuroligins, like neurexins, undergo alternative
splicing in their extracellular domain, but only at two sites:
A (adding up to 40 aa) and B (adding a 9 aa insert) (Comoletti
et al., 2006). Interactions between members of the neurexin
and neuroligin family appear highly regulated by a ‘‘splice-insert
signaling code’’ (Boucard et al., 2005; Chih et al., 2006; Graf
et al., 2006; Kang et al., 2008). Key features of this code involve:
(1) a pronounced binding preference between specific neurexin
alternative splice isoforms and specific neuroligin alternative
splice isoforms (Boucard et al., 2005; Chih et al., 2006; Graf
et al., 2006; Kang et al., 2008), and (2) a distinct distribution of
neuroligin isoforms between excitatory (NL1/3/4) and inhibitory
synapses (NL2) (Song et al., 1999; Graf et al., 2004; Varoqueaux
et al., 2004; Prange et al., 2004; Chih et al., 2005; Levinson and
El-Husseini, 2005; Chubykin et al., 2007). In particular, the pres-
ence of a 30 amino acid splice insert at site SS#4 in n1b
(n1b+SS#4) favors binding to neuroligin 2 (which is not spliced
at site B and is found at GABAergic synapses) promoting
GABAergic over glutamatergic synaptogenesis. N1b+SS#4ts reserved
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a splice insert at their site B. In contrast, n1bwith no splice insert
at SS#4 interacts with neuroligin isoforms regardless of whether
the latter are spliced at their site B, and consequently n1b is
found at both glutamatergic as well as GABAergic synapses.
The neurexin-neuroligin interaction is likely of fundamental
importance because an imbalance of excitatory versus inhibitory
synaptic activity is thought to be at the basis of a number of neu-
rological disorders, and indeed mutations in neuroligins as well
as neurexins have been linked to autistic spectrum disorder
(Jamain et al., 2003; Laumonnier et al., 2004; Cline, 2005;
Garber, 2007; Szatmari et al., 2007; Tabuchi et al., 2007).
To understand the mechanism by which alternative splicing
of n1b generates selective preference for neuroligin isoforms,
we solved the structure of n1b_L/n1a_L6 carrying its natural
30 amino acid alternative splice insert at splice site SS#4 (abbre-
Figure 1. Neurexin Topology
(A) Extracellular domain of neurexin 1a (n1a) and neurexin 1b (n1b). LNS/LG
domains (abbreviated from laminin, neurexin, sex hormone binding globulin/
laminin G domain) are indicated as gray squares labeled ‘‘L1’’ through ‘‘L6,’’
or in the case of neurexin 1b, ‘‘L.’’ EGF-like domains (abbreviated from epider-
mal growth factor) are shown as black ovals labeled ‘‘A’’, ‘‘B’’, and ‘‘C’’. A short
b-neurexin-specific sequence is indicated as ‘‘b-specific.’’ In addition to the
extracellular domain, neurexins also contain a signal peptide, single transmem-
brane segment, and a cytoplasmic tail (not shown). The five positions in the
extracellular domain of a-neurexins that accommodate splice-insert sites are
indicated (SS#1, SS#2, SS#3, SS#4, and SS#5) as well as the two splice-insert
sites found in b-neurexins (SS#4 and SS#5). In the rat and bovine species,
n1a_L4 accommodates a glycine or a 10 aa insert at SS#3 (DCIRINCNSS),
and n1b_L (with identical sequence to n1a_L6) accommodates either no insert
or a 30 aa sequence at SS#4 (GNNDNERLAIARQRIPYRLGRVVDEWLLDK)
(Ushkaryov et al., 1992; Ullrich et al., 1995).
(B) Structure of n1a_L2 (Sheckler et al., 2006). The splice insert sites SS#2,
SS#3, and SS#4 are shown in yellow, green, and magenta, respectively, form-
ing a region called the ‘‘hypervariable surface’’ shaded in gray. A Ca2+ ion is
observed experimentally in n1a_L2 at the center of the hypervariable surface,
shown as a blue sphere. Loops b2-b3, b6-b7, and b10-b11 identified to be
crucial for synaptogenic activity and neuroligin binding are indicated (Graf
et al., 2006).Structureviated here to n1b_L(30)) at 1.72 A˚ resolution in aCa2+-containing
form. To directly assess the structural impact of the splice insert
at SS#4, we also solved the structure of the splice-insert-free
n1b in the presence of Ca2+ because only the metal-free form
of n1b was known (Rudenko et al., 1999). To ascertain if the
forms of n1b_L/n1a_L6 with or without a splice insert have
Ca2+-binding sites at the hypervariable surface with characteris-
tic properties, we additionally solved the structure of n1a_L4 in
the splice-insert-free form. Our studies reveal major changes
to the shape of n1b_L/n1a_L6 upon incorporation of the splice
insert at SS#4, not only adding secondary structure but also
inducing major rearrangements to a key portion of the hypervari-
able surface. The rearrangements affect key residues in loop
b10-b11 that lines the hypervariable surface and is important
for neuroligin binding. In addition, the presence of SS#4
increases the Ca2+-binding affinity of n1b, though overall the
Ca2+-binding affinity appears low for the neurexin LNS/LG do-
mains tested (n1b ± SS#4 and n1a_L4 ± SS#3). Our results indi-
cate that incorporation of alternative splice inserts into neurexin
LNS/LG domains can introduce profound changes to their struc-
tural and biochemical properties.
RESULTS
Structure of n1b_L(30)
The structure of n1b_L(30) was solved in presence of Ca2+ and
refined to 1.72 A˚ (Table 1 and Experimental Procedures). Two in-
dependent monomers are found in the asymmetric unit with 198
and 196 aa, respectively (residues 80–294 and 80–292), each
comprising 14 b strands and 2 a helices (Figure 2). Electron den-
sity is not observed for the residues 199–215 in either monomer.
Accommodating a Splice Insert at Splice Site SS#4
The 30 amino acid splice insert Gly201-Lys230 interrupts loop
b10-b11 at the hypervariable surface with residues Pro216-
Lys230 forming part of helix Sa1 that protrudes perpendicularly
into space (Figure 2). The helix Sa1 extends out more than
28 A˚, almost doubling the height of the monomer (Figure 2),
and adopts the same orientation in both molecules with respect
to the b sandwich (Figure 3A).
Superimposing the molecules (using all 196 common Ca
atoms, rmsd of 0.26 A˚) places the two Sa1 helices <2 apart
(rmsd of 0.39 A˚ for 18 Ca atoms Arg218-Thr235). However, the
Sa1 helices make a number of contacts with symmetry related
molecules in the crystal lattice, which could influence their orien-
tation. The high quality of the electron density shows that the Sa1
helices are well ordered, unlike residues Gly201-Ile215 of the
splice insert that are too flexible to be observed (Figures 3B
and 3C).
Structural Rearrangements Take Place
to Accommodate Sa1
We compared the structures of n1b_L(30) and n1b (Table 1) in
their Ca2+-containing forms to identify the structural rearrange-
ments that accompany the integration of the splice insert at
SS#4. In n1b, loop b10-b11 traverses the edge of the sandwich
forming an integral part of the hypervariable surface (Figure 4A,
refer also to Figure 1B). In n1b_L(30), the extra residues added
by the splice insert do not interact with the rest of the molecule16, 422–431, March 2008 ª2008 Elsevier Ltd All rights reserved 423
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Neurexin LNS/LG Splice IsoformsTable 1. Data and Refinement Statistics Summary for n1b_L(30), n1b + Ca2+, and n1a_L4
Structure n1b_L(30) n1b+Ca2+ n1a_L4
Data Statistics
Resolution (A˚)a 19.9–1.72 (1.76–1.72) 40.6–2.60 (2.64–2.60) 23.7–1.04 (1.08–1.04)
Reflectionsb 406535/49688 362517/73949 1039051/82197
Multiplicity 8.2 4.9 12.6
Completeness (%) 92.1 (73.1) 99.9 (99.8) 92.9 (60.5)c
Rmerge (%)
d 5.4 (35.5) 6.5 (42.3) 7.0 (29.6)
I/s 25.9 (3.1) 24.8 (4.3) 37.9 (6.2)
Refinement Statistics
Resolution (all reflections jFj/sR 0.0) 19.9–1.72 A˚ 20.0–2.6 A˚ 23.7–1.04 A˚
Protein atoms (as alternative conformation) 3023 atoms (95 atoms) 12111 1477 (214)
Protein residues 394 1600 175
Solvent atoms 353 113 130
Molecules in asymmetric unit 2 9 1
Ligands 2 Ca2+ 3 Ca2+ 1 Ca2+
Unique reflections 49679 73564 80871
Working set/test set 45909/3770 69823/3741 72763/8108
Rwork 19.75% 20.27% 14.65%
Rfree 22.47% 24.4% 16.52%
Rmsd bond lengths 0.023 A˚ 0.017 A˚ 0.016 A˚
Rmsd bond angles 1.7 1.6 1.9
Rmsd NCS-related molecules (no. Ca atoms) 0.26 A˚ (196) 0.50 A˚ (173e) n.a.
Bave of main chain atoms (no. atoms)
f 25.2 A˚2 (1576) 39.8 (6400) 12.9 A˚2 (700)
Bave of side chain atoms (no. atoms)
f 27.3 A˚2 (1447) 40.6 A˚2 (5711) 15.3 A˚2 (777)
Bave of solvent atoms (no. atoms)
f 31.1 A˚2 (353) 33.0 A˚2 (113) 20.5 A˚2 (133)
Bave of Ca
2+-ions (no. ions)f 20.9 A˚2 (2) 43.7 A˚2 (3) 6.7 A˚2 (1)
a Outer shell statistics in parentheses.
b Total/unique reflections.
c 1.08–1.12 A˚ 84.6% complete, rest of shellsR95.7%.
dRmerge = S j (I  <Imean>) j / S (I).
e Except mol I with 151 Ca atoms.
f Bave = average residual B factor after TLS refinement by REFMAC.(Figure 4A). However, in order to accommodate Sa1, residues in
loop b10-b11 undergo drastic rearrangement altering their con-
formation compared to n1b (Figure 4A). Residues Gly231-Thr235
that in n1b contribute to the long and extended loop b10-b11 tra-
versing the rim of the b sandwich, rearrange in n1b_L(30) into
a helical conformation to form part of Sa1 (Figure 4B). In partic-
ular, Gly231- Arg232 adopt an a-helical conformation, and Gln233-
Leu234-Thr235 convert to a 310 helix extending Sa1 in n1b_L(30).
The three residues N-terminal to SS#4 (Tyr198, Pro199, and Ala200)
are disordered in n1b_L(30) unlike in n1b (Figures 4A and 4B).
Structural Characterization of Ca2+-Binding Sites
of n1b_L(30), n1b, and n1a_L4
To investigate if the Ca2+-binding sites at the hypervariable
surfaces are coupled to alternative splicing of neurexin LNS/LG
domains, we first identified the Ca2+-binding sites in the struc-
tures of n1b_L(30), n1b, and n1a_L4 in presence 5 mM Ca2+.
A Ca2+ ion was identified in n1b_L(30) by difference Fourier tech-
niques (see Experimental Procedures). The Ca2+ is bound at the
hypervariable surface with approximate octahedral geometry
displaying Ca2+ to oxygen distances of 2.34–2.50 A˚ (as typical424 Structure 16, 422–431, March 2008 ª2008 Elsevier Ltd All rightsfor proteins) (Harding, 2006) chelated by side chains Asp137
and Asn238, main chain carbonyls from Val154, Ile236, and Q233;
the coordination (n = 6) is completed by a water molecule
(Wat1279 in mol A and Wat1211 in mol B) (Figure 5A). Difference
Fourier techniques revealed a Ca2+ ion bound at the hypervari-
able surface of n1b as well (see Experimental Procedures). The
Ca2+ ion is bound with approximate octahedral geometry
by side chain oxygens from Asp137 and Asn238, main chain car-
bonyls from Val154 and Ile236 at Ca2+ to oxygen distances in the
range 2.26–2.66 A˚, while coordination n = 6 is completed by two
water molecules (shown for monomer D) (Figure 5B). Only three
out of nine n1b molecules in the asymmetric unit contain an ion
bound at the Ca2+-binding site, because an arginine residue
from a neighboring molecule (Arg109 or Arg286) forms a salt
bridge with Asp137 blocking access in the rest of the molecules.
While amino acid sequence conservation predicts a Ca2+-bind-
ing site at the hypervariable surface of n1a_L4, formed by the
side chain of Asp772 (Od2), and main chain carbonyl oxygens
from Leu789 and Arg848 (Figure 5C), in the crystal structure deter-
mined to 1.04 A˚ (Table 1), we find electron density that we inter-
pret as amixture between a Ca2+ ion (with three water moleculesreserved
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+/
NH2 group occupying roughly the same position as the Ca
2+
ion (an interpretation that is warranted by the very high resolution
of the diffraction data) (Figures S1A, S1B, and S1C, see the
Supplemental Data available with this article online). N1a_L4
crystals were exposed to Tris-buffer less than one half hour prior
to data collection, suggesting that n1a_L4 has a surprisingly
weak Ca2+-binding site.
Comparing the Ca2+-binding site for n1b_L(30) and n1b
reveals that incorporation of the splice insert at SS#4 alters the
Ca2+-binding site of n1b_L/n1a_L6 structurally (Figures 5A and
5B). The rearrangements incurred to incorporate Sa1 in
n1b_L(30), alteringGly231-Thr235 froman extended loop into a he-
lical conformation, work to reposition Gln233 so that it ligands the
Ca2+ ion with its backbone carbonyl, thereby displacing a water
molecule (Wat92) that occupies the same position in n1b as well
as more fully burying the Ca2+ ion (Figures 5A and 5B). So, while
no residue of the splice insert directly interacts with Ca2+-binding
site, its incorporation results in an additional protein ligand being
provided to the Ca2+ ion contributed by loop b10-b11. Our struc-
tures reveal that the minimal Ca2+-binding site in neurexin LNS/
LG domains is formed by a side chain of an conserved aspartic
acid residue and twomain chain carbonyl residues, but that Ca2+
coordination is completed in very different ways leaving the Ca2+
ion solvent exposed (such as in n1a_L2 and n1a_L4) or almost
completely buried, such as seen in n1b_L(30) where it is coordi-
nated by five protein ligands (Figure 5C).
Alternative Splicing of Neurexin LNS/LG Domains
Regulates Ca2+-Binding Affinity
To understand if the presence of alternative splice inserts
changes the affinity of the Ca2+-binding sites, we used isother-
mal titration calorimetry (ITC) to characterize Ca2+-binding to
n1b and n1a_L4 and their respective splice isoforms. Titration
of a Ca2+-containing solution into n1b carrying the 30 aa splice
insert at SS#4 (0.35 mM n1b+SS#4, 8.1 mM CaCl2) generated
Figure 2. Ribbon Diagram of n1b_L(30)
(A and B) The b sandwich is shown in a face view (left) and side view (right).
b strands are depicted as light blue arrows. Helical residues are shown in pink
with theexceptionof the residuesbelonging to the 30amino acid splice insert at
SS#4, which are shown in magenta (part of helix Sa1). Residues Pro199-Ile215
(part of loop b10-b11) are not visible in the structure and are depicted here
as a dotted line. A Ca2+ ion is observed at the hypervariable surface, shown
as a blue sphere, the N terminus and C terminus of the polypeptide chain are
indicated with ‘‘N-term’’ and ‘‘C-term,’’ respectively. Dimensions for the b
sandwich (cyan) and the protruding helix Sa1 (pink/magenta) are indicated.Figure 3. Helix Sa1 Adopts a Well-Defined
Orientation in the Crystal Structure of
n1b_L(30)
(A) Superposition of the crystallographically inde-
pendent n1b_L(30) molecules A (magenta) and B
(yellow) found in the asymmetric unit. The Ca2+
ion is shown as a blue sphere.
(B) Omit map density for Sa1 in molecule A.
(C) Omitmap density for Sa1 inmolecule B. (B) and
(C) display electron density contoured at 1s from
simulated annealed composite omit maps calcu-
lated by CNS (Brunger et al., 1998).Structure 16, 422–431, March 2008 ª2008 Elsevier Ltd All rights reserved 425
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that slowly saturated, indicating ametal-binding site increasingly
occupied by Ca2+ (Figure 6A). Titration of n1b lacking the splice
insert at SS#4 with Ca2+ (under the identical experimental condi-
tions) generated a clear but much weaker exothermic reaction
that did not saturate significantly, indicating lower affinity
(Figure 6B). The heat evolved through titration of Ca2+ into
n1a_L4 or its splice isoform n1a_L4(10) with an insert at SS#3
(0.35 mM protein in a GST-fusion form to increase solubility,
6 mM CaCl2) generated a very weak endothermic reaction,
only slightly larger than the heat evolved upon dilution of the
Ca2+ into buffer, indicating that Ca2+-binding was poorly/not
measurable under the experimental conditions (Figure S2). We
conclude that alternative splicing of n1b alters both its three-
dimensional structure, as well as its Ca2+-binding site, impacting
the affinity for Ca2+ in a domain-specific way.
DISCUSSION
Neurexins form a large family of synaptic adhesion molecules
diversified through alternative splicing. The trans-synaptic
bridge formed between specific presynaptic neurexin alternative
splice isoforms and specific postsynaptic neuroligin alternative
Figure 4. Structural Comparison of n1b_L(30) and n1b
(A) Superposition of n1b_L(30) (gray Ca trace) and n1b (cyan trace). The Sa1
helix seen only in n1b_L(30) is shown in maroon (the splice insert residues
Pro216-Lys230) and in yellow (residues Gly231-Thr235). The residues Gly231-
Thr235 in n1b are displayed in orange.
(B) Close up of the structural rearrangements that occur to loop b10-b11 upon
incorporation of a splice insert at SS#4 in n1b. N1b_L(30) in gray, yellow, and
maroon, and n1b in cyan. Relevant side chains are depicted in ball and stick
(carbon, yellow or cyan; nitrogen, blue; and oxygen, red, respectively). The
Ca2+ ion is shown as a blue sphere. A cyan arrow indicates where the
splice-insert site SS#4 maps in n1b.426 Structure 16, 422–431, March 2008 ª2008 Elsevier Ltd All rightsplice isoforms promotes excitatory and inhibitory synaptogen-
esis in vitro, controlling their balance. A ‘‘splice-insert signaling
code’’ is exploited regulating mutual binding affinities. In partic-
ular, studies using recombinant proteins as well as cell-surface
binding assays have revealed that n1b binds all four neuroligin
1 splice isoforms (i.e., +A+B, +AB, A+B and AB) and
both neuroligin 2 isoforms (+A and A), while n1b+SS#4 binds
only isoforms of neuroligin 1 lacking the B insert (i.e., +AB
and AB) and both neuroligin 2 isoforms (i.e., +A and A, as
neuroligin 2 is not spliced at the B site) (Boucard et al., 2005;
Chih et al., 2006). Incorporation of a 30 aa splice-insert site at
SS#4 in n1b therefore promotes inhibitory synapse formation
in vitro because on the one hand, binding to neuroligin 2 is main-
tained that is specific to inhibitory synapses, and on the other
hand, binding is reduced to neuroligin isoforms that carry splice
inserts at their site B and are located predominately at glutama-
tergic synapses (Boucard et al., 2005; Chih et al., 2006; Graf
et al., 2006).
Wehave solved the structure of n1b_L(30) carrying its 30 amino
acid alternative splice insert at splice site SS#4, to our knowl-
edge the first structure of a neurexin LNS/LG domain accommo-
dating a splice insert. The structure reveals that: (1) the 30 aa
splice insert does not make contact with the rest of the molecule
but forms a long a helix protruding from the hypervariable sur-
face; (2) incorporation of the splice insert at SS#4 results in dra-
matic structural rearrangements to residues outside the splice
insert, changing the molecular shape and properties of the hy-
pervariable surface; and (3) the Ca2+-binding site is rearranged
to more fully obscure the Ca2+ from solvent indeed increasing
its Ca2+-binding affinity (as observed by ITC). The conformation
of helix Sa1 observed in the crystal structure may represent its
solution structure as well (as opposed to being the result of
lattice contacts) because (1) secondary structure prediction
programs indicate that the splice insert contains helical content;
(2) the Sa1 helices, though stabilized by the crystal packing, are
identically orientated with respect to their b sandwich cores in
the two crystallographically independent molecules; and finally,
(3) the Ca2+-binding site at the hypervariable surface of
n1b_L(30) anchors one end of the Sa1 helix in place. However,
in the context of a complex with neuroligin helix Sa1 may
undergo structural changes to adopt quite another conformation
(see further on in Discussion). In stark contrast, structures of the
Ca2+-containing forms of n1b and n1a_L4 reveal a large flat and
open hypervariable surface with metal-binding sites that appear
by ITC to be weakly occupied (if at all) and are largely solvent
accessible.
Impact of an Alternative Splice Insert at SS#4
The rearrangements observed in n1b_L(30) reveal a structural
mechanism for the regulatory effect imparted by the splice insert
at SS#4 and a mechanism for generating neuroligin splice iso-
form specificity. Studies probing neuroligin 1 binding through
mutagenesis of neurexin 1b pin-pointed the hypervariable sur-
face as being an essential protein:protein interaction site (Graf
et al., 2006). In particular, polyalanine replacement of loop b2-
b3 (Ser107Thr108Arg109), loop b6-b7 (Val154Gly155Thr156Asp157),
or loop b10-b11 (Arg232Gln233Leu234Thr235), loops surrounding
the Ca2+-binding site central to the hypervariable surface (Fig-
ure 1), completely abolished both inhibitory as well as excitatorys reserved
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Neurexin LNS/LG Splice IsoformsFigure 5. Ca2+-Binding Sites in Neurexin LNS/LG Domains
(A) Ca2+-binding site observed in n1b_L(30).
(B) Ca2+-binding site observed in n1b.
(C) Schematic comparison of experimentally determined Ca2+-binding sites in neurexin LNS/LG domains n1a_L2, n1a_L4, n1b_L/n1a_L6, and n1b_L(30)/
n1a_L6(30), with information for n1a_L2 obtained from Sheckler et al. (2006). Relevant side chains are depicted in ball and stick (carbon, yellow or gray; nitrogen,
blue; and oxygen, red, respectively). The Ca2+ ion is shown as a blue sphere.synaptogenic activity in neuron:transfected fibroblast coculture
assays, while other loops tested had no effect. These studies
also showed that synaptogenic activity is abolished by mutation
Arg109Ala on b2-b3 and diminished bymutation Asp158Ala in loop
b6-b7, residues on either side of the Ca2+-binding site. Impor-
tantly, the individual mutations Arg232Ala, Gln233Ala, and
Thr235Ala displayed a regulatory effect because they only some-
what affected synaptogenic activity at inhibitory synapses (in-
volving neuroligin 2) but significantly depressed synaptogenic
activity at excitatory synapses (presumably involving neuroligin
isoforms with a splice insert at site B). Direct cell-surface binding
studies showed that these same point mutations disrupted both
neuroligin 1 (+B) and neuroligin 2 binding but impacted the
former more than the latter, indicating that residues Arg232,
Gln233, and Thr235 appear to discriminate between neuroligin
(splice) isoforms.
Our structures reveal a molecular mechanism for the genera-
tion of splice-isoform-specific neuroligin interactions whereby
the shape of the hypervariable surface is grossly altered by
the presence of helix Sa1, and whereby ‘‘switch’’ residues
Gly231Arg232Gln233Leu234Thr235 (loop b10-b11) occupy drasti-
cally different conformations in n1b_L(30) compared to the
splice-insert-free n1b (for example, counterparts for Arg232 and
Gln233 locate roughly 15.5 A˚ apart in the two structures) (Fig-
ure 4B). Only certain neuroligin-binding epitopes, however, are
targeted for rearrangement because residues Arg109 in loop
b2-b3 andAsp158 in loop b6-b7 (crucial for binding neuroligins re-
gardless of splicing at their B site and essential for both inhibitory
and excitatory synaptogenic activity) are in the same conforma-
tion in n1b and n1b+SS#4. Though helix Sa1 may undergo con-
formational changes upon neuroligin binding, its presence none-
theless must drastically influence the binding surfaces that can
be generated. Our results indicate that b neurexins employ
a ‘‘splice-insert-blocked’’ or ‘‘splice-insert-open’’ hypervariable
surface together with switch residues Gly231Arg232Gln233
Leu234Thr235 to generate distinctly different binding surfaces
that discriminate between different neuroligins splice isoforms.Structure 1While this work was under peer review, three structures of
neurexin 1b in complex with either neuroligin 1 or neuroligin
4 were published (Arac¸ et al., 2007; Chen et al., 2007; Fabrichny
et al., 2007). Using the highest resolution coordinates available
(Arac¸ et al., 2007), we docked n1b_L(30) onto n1b found in the
complex with neuroligin 1B (A B) (rmsd of 0.5 A˚ using
168 Ca atoms). It is immediately clear that the interface between
neuroligin 1 and n1b is disrupted by the presence of the splice
insert at SS#4 (Figure 7A). In particular, the mechanism by which
neuroligin 1 interacts with the Ca2+-binding site of n1b using side
chain E397 and backbone carbonyl Q395 to interact with the Ca2+
ion in a water-mediated manner (Chen et al., 2007; Arac¸ et al.,
2007) is not possible in n1b+SS#4 because one of its ‘‘switch’’
residues Q233 located in loop b10-b11 blocks access, while its
backbone carbonyl ligands the Ca2+ ion (Figure 7B). If helix
Sa1 is anchored by its interaction to the Ca2+ ion, then an
n1b+SS#4:neuroligin complex would require neuroligin to pivot
to an alternate position (and binding mode) to accommodate
splice insert SS#4, or neuroligin to either bend helix Sa1 out of
the way or displace Sa1 from the Ca2+-binding site by inducing
conformational rearrangements. The presence of an insert at
site B in neuroligin could hinder rearrangements required to
form an n1b+SS#4:neuroligin complex, thus explaining why
inserts at site B and SS#4 appear less compatible together.
Ca2+-Binding in Neurexin LNS/LG Domains
Our structures suggest that Ca2+ plays different roles in mediat-
ing neuroligin binding to n1b in presence or absence of a splice
insert at SS#4. The Ca2+-binding site at the hypervariable
surface is absolutely essential for binding neuroligins because
mutating the n1b ligands chelating the Ca2+ ion abolishes synap-
togenic activity (Graf et al., 2006). The structural mechanism of
Ca2+-dependent ligand binding in the splice-insert-free form of
n1b (which is very similar in the Ca2+-free and Ca2+-bound
form, results not shown) entails ligand completing the Ca2+ coor-
dination mediated by a water molecule (Arac¸ et al., 2007; Chen
et al., 2007; Fabrichny et al., 2007). However, in the case of6, 422–431, March 2008 ª2008 Elsevier Ltd All rights reserved 427
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of Ca2+-dependent ligand binding likely involves Ca2+ playing
a key structural role, keeping the helix Sa1 helix fixed with
respect to the rest of the molecule in a binding compatible or
incompatible mode as required by the ‘‘splice-insert signaling
code.’’ In the physiological context of the synapse, it remains
to be determined if the increase in Ca2+ affinity observed for
n1b+SS#4 is important for neuroligin binding and whether the af-
finity of the Ca2+-binding site is further altered upon association
with neuroligin.
Overall, the different neurexin LNS/LG domains in their iso-
lated form appear to have surprisingly weak affinity Ca2+-binding
sites, even though the domains n1a_L2, n1a_L2(8), n1a_L2(15),
n1b, n1b+SS#4, n1a_L4, and n1a_L4(10) have required different
experimental conditions for our ITC experiments complicating
direct comparison (results presented here; Sheckler et al.,
2006; Chen et al., 2007). Of course, in the context of the intact
neurexin ectodomains or as complexes with their respective
protein partners, the affinities of these Ca2+-binding sites likely
Figure 6. Isothermal Titration Calorimetric Studies of n1b+SS#4
and n1b
Titrations were carried out with a Microcal VP-ITC as described in the Exper-
imental Procedures. Each spike (with the exception of the first) represents the
heat evolved in mcal/sec as a result of a 5 ml injection of CaCl2. (A) 0.35 mM
n1b+SS#4 in CHELEX-treated buffer (10 mM HEPES [pH 8], 100 mM NaCl)
titrated with 8.1 mM CaCl2 at 5
C. (B) 0.35 mM n1b in CHELEX-treated buffer
(10 mM HEPES [pH 8], 100 mM NaCl) titrated with 8.1 mM CaCl2 at 5
C. For
each run, the heat of dilution of Ca2+ into buffer is shown obtained by carrying
out an identical titration into buffer but with no macromolecule present (top
trace in each figure, vertically offset by an arbitrary amount for visualization
purposes). Both for n1b+SS#4 and n1b, the heat evolved per injection was
small, and binding did not reach saturation precluding the fitting of a binding
isotherm and derivation of a binding constant; titrations using higher protein
concentrations were not possible due to limited protein solubility.428 Structure 16, 422–431, March 2008 ª2008 Elsevier Ltd All rightschange. Our findings nevertheless suggest that if Ca2+ levels
do indeed fluctuate at the synaptic cleft, as has been suggested
(Stanley, 2000; Smith et al., 2004; Hardingham et al., 2006), that
neurexin protein:protein interactions might potentially be influ-
enced. Alternative splicing as amechanism to control Ca2+-bind-
ing sites has been shown in the case of the cytomatrix protein
piccolo; however, this protein is located at the presynaptic termi-
nals, intracellularly at the active zone, where huge Ca2+ fluctua-
tions are known to occur (Garcia et al., 2004). Our studies indi-
cate that neurexin splice isoforms also possess distinct
molecular, structural, and Ca2+-binding properties and as such
could be exploited to fine tune neural network function and
formation.
The recent finding that alterations in neurexins are linked with
autism spectrum disorder (Szatmari et al., 2007), as indeed has
also been shown for neuroligins, and the lethality observed in
a-neurexin knockout mice (Missler et al., 2003) suggest that
neurexins are fundamentally important for proper brain function
and human mental health. Study of isolated neurexin LNS/LG
domains already provides important clues how alternative
splicing of neurexin isoforms can subtly control synaptic protein
interactions.
EXPERIMENTAL PROCEDURES
Protein Overexpression and Purification
Rat neurexin 1b in the splice-insert-containing (n1b+SS#4), the insert-free form
(n1b), as well as the isolated LNS/LG domain (residues Ser77-Ser294) in the
insert-containing form (n1b_L(30)) were expressed as thrombin-cleavable glu-
tathione-S-transferase (GST) fusion proteins in E. coli BL21 (DE3) cells, while
the fourth LNS/LG domain (residues Arg721-Ile909) from bovine neurexin 1a in
the splice-insert-containing (n1a_L4(10)) and the insert-free form (n1a_L4)
were expressed as GST-fusions in Origami B cells. Proteins were purified as
described by Rudenko et al. (1999) and Sheckler et al. (2006) as well were
the intact GST-fusion proteins GST-n1a_L4 and GST-n1a_L4(10). As a final
step, proteins were subject to size-exclusion chromatography (Superdex
Figure 7. Splice Insert SS#4 Disrupts the Protein:Protein Interface
Seen in the n1b:Neuroligin 1 Complex
(A) Superposition of n1b_L(30) (gray Ca trace) onto n1b (light cyan Ca trace) of
the n1b:neuroligin 1 complex (PDB code: 3BIW), with neuroligin 1 shown as
a cyan Ca trace. The splice insert residues are in maroon, ‘‘switch’’ residues
in yellow (n1b_L(30)) or orange (n1b), respectively.
(B) Close up of the Ca2+-binding site in n1b_L(30) as docked on n1b of the
n1b:neuroligin 1 complex. N1b_L(30) shown in gray and yellow, neuroligin 1
in cyan. Relevant side chains are depicted in ball and stick (carbon, gray, yel-
low, or cyan; nitrogen, blue; oxygen, red). The Ca2+ ion is shown as a blue
sphere. For the sake of clarity, the side chain Ile236 of n1b_L(30) and the trace
of n1b are not shown. Orange arrows indicate the side chain of Glu397 andmain
chain carbonyl of Gln395 from neuroligin 1 that undergo (water-mediated) inter-
action with the Ca2+-binding site of n1b (Arac¸ et al., 2007; Chen et al., 2007).reserved
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Neurexin LNS/LG Splice Isoforms200 16/60) in 20 mMHEPES (pH 7.5), 150 mM NaCl, 1 mM EDTA and concen-
trated to 8.5–10 mg/ml for n1b_L(30), n1b, and n1b+SS4. N1a_L4 and
n1a_L4(10) were typically gel filtrated in 20 mM MES (pH 6), 150 mM NaCl,
1 mM EDTA and concentrated to 3 and 5 mg/ml, respectively, for structural
studies. Protein concentrations were determined by using the method of
Pace et al. (1995) and the BIORAD protein assay with BSA as a standard.
The residue numbering scheme for the domains assumes the presence of
a splice insert at SS#3 (10 residues) and SS#4 (30 residues).
Crystallization and X-Ray Data Collection
N1b_L(30) was crystallized with the symmetry of spacegroup P21 (cell dimen-
sions a = 84.1 A˚, b = 39.3 A˚, c = 85.4 A˚, b = 115.5) by using the hanging-drop
method with a reservoir solution (1000 ml) containing 17%Peg 8000, 0.1 M Tris
(pH 8.5), 0.2 MMgCl2, 5 mMCaCl2, 0.5% b-octyl-glucoside at 4
C. Crystals of
at least 0.3 mm in size were obtained within 1–2 weeks by microseeding hang-
ing drops containing 1 ml of protein at 10 mg/ml and 1 ml reservoir solution;
crystals were cryo-protected in paratone N oil: mineral oil (1:1) and flash frozen
in liquid propane. N1b was crystallized with the symmetry of spacegroup
P21212 (a = 116.7 A˚, b = 195.7 A˚, c = 103.9 A˚) as described in Rudenko
et al. (1999). Crystals were soaked for 21 hr in Ca2+-containing mother liquor
(24% Peg 5000 MME, 50 mM NaCacodylate [pH 6.5], 5 mM AmSO4, 5 mM
CaCl2), cryo-protected with additional presence of 30%glycerol, and flash fro-
zen in liquid propane. Crystals of n1a_L4 in the splice-insert-free form (space-
group P63 and cell dimensions a = 90.3 A˚, b = 90.3 A˚, c = 39.6 A˚) were grown by
using the hanging-drop method with a reservoir solution (1000 ml) containing
12.5% isopropanol, 0.1 M CHES (pH 9.0), 5 mM CaCl2 at 20
C and hanging
drops containing 1 ml of protein at 3 mg/ml and 1 ml reservoir solution. Crystals
of the size 0.2–0.3 mm were obtained within 1 week, cryo-protected in 10%
isopropanol, 0.1 M Tris (pH 8.5), 5 mM CaCl2, 40% Peg 400 for 20 min, and
flash frozen in liquid propane. N1a_L4 crystals were also soaked for 14 hr in
10% isopropanol, 0.1 M Tris (pH 8.5), containing 1 mM ErCl3 or 5 mM SrCl2
to replace Ca2+, and then cryo-protected and frozen in the same manner.
Crystals of n1a_L4(10) were not obtained, in spite of extensive screening for
crystallization conditions.
Diffraction data for n1b_L(30) crystals were collected at APS COMCAT
beamline (32-ID) on a MAR CCD 165 mm in unbinned mode at 1.0000 A˚ wave-
length by using a single crystal. The data was processedwithMOSFLM (Leslie,
1992) and programs from the CCP4 suite (CCP4, 1994). Diffraction data for n1b
crystals soaked in Ca2+were collected at APS 19-BMon a custombuilt CCD at
0.9795 A˚ wavelength by using a single crystal. The data was processed with
HKL2000 (Otwinowski and Minor, 1997) and programs from the CCP4 suite
(CCP4, 1994). Diffraction data for n1a_L4 crystals were collected at APS
GM/CA-CAT beamline (23-ID) on aMAR CCD 300mm at 0.9611 A˚ wavelength
on a single crystal. The data was processed with HKL2000 (Otwinowski and
Minor, 1997) and programs from the CCP4 suite (CCP4, 1994). Additional
data was collect at LS-CAT 21-ID at APS on a MAR CCD 165 mm at 1.2795 A˚
and 0.7689 A˚ for crystals soaked in Er3+ and Sr2+, respectively. Data statistics
for the data sets (all collected under cryogenic conditions) are given in Table 1.
Structure Determination, Model Building, and Refinement
The structures of n1b_L(30) and n1a_L4 were determined by molecular
replacement with CNS (Brunger et al., 1998) by using n1b with no splice insert
in the Ca2+-free form (PDB code: 1C4R) as a search model. N1b_L(30) was re-
fined to 1.72 A˚ and contains two monomers in the asymmetric unit. N1a_L4
was refined to 1.04 A˚ and contains one monomer per asymmetric unit (resi-
dues 723–906). The structure of n1b in the Ca2+-bound form was determined
by rigid-body refinement of the eight molecule packing determined for n1b in
the Ca2+-free form (PDB code: 1C4R) (Rudenko et al., 1999). Amazingly, upon
soaking the n1b crystals in a Ca2+-containing mother liquor, a ninth molecule
becomes ordered in the crystals with interpretable electron density for all
but five stretches of polypeptide, the largest being 11 residues long. Structures
were built with O (Jones et al., 1991) and refined with REFMAC (Murshudov
et al., 1997) (Table 1). The structures for n1a_L4, n1b, and n1b_L(30) have
been deposited in the Protein Data Bank (PDB codes: 2R16, 2R1D, and
2R1B). The structures were validated with PROCHECK (CCP4, 1994). The
Ramachandran plot reveals for n1b_L(30) that 88.6% of the residues are in
the most favored regions, 9.8% in the additionally allowed region, and no res-
idues are in the disallowed region; for n1a_L4 that 91.6% of the residues are inStructure 1the most favored regions, 8.4% in the additionally allowed region, and no
residues are in the disallowed region; and finally for n1b+Ca2+ that 85.1% of
the residues are in the most favored regions, 13.7% in the additionally allowed
region, and three residues out of a total of 1600 residues (0.2%, nine mole-
cules) are in the disallowed region. Figures were made with Molscript (Kraulis,
1991) and Raster3D (Merritt and Bacon, 1997).
Identification of Ca2+-Binding Sites
Ca2+-binding sites in n1b_L(30) were identified as two strong positive electron
densities (22.6 and 19.6 s) corresponding to a single Ca2+ ion bound at the
hypervariable surface in each monomer in sigmaA-weighted difference Fourier
maps (with coefficients mjFoCa2+j-DjFcCa2+-freej and phases calculated with
a protein/solventmodel but no calcium atoms). A Ca2+-binding site at the hyper-
variable surface of n1b was identified in three molecules (mol B, D, I) by using
two separate difference Fourier maps: (1) diffraction data from a crystal in pres-




-free) and combinedwithphases fromamodelwith solvent
but no Ca2+ ions, revealing three strong density peaks (5.9, 6.9, and 7.5 s);
and (2) a sigmaA-weighted omit map (coefficients mjFoCa2+j-DjFcmodel  Ca2+j
and phases calculated from a protein/solvent model minus calcium atoms)
also revealed three strong positive electron densities (10, 9.5, and 7.2 s).
A second possible site (Site II) was observed in n1b and n1b_L(30) in the sharp
loop b4-b5 at the hypervariable surface formed by side chain oxygen from
Ser131, main chain carbonyls from Ser131, Ser132, Leu135, and completed by
twowatermolecules (not shown). However, given the long distances to ligands
(up to 2.5–2.7 A˚) and inconsistent presence in difference Fourier maps, the ex-
istence of Site II is unclear. The Ca2+-binding site in n1a_L4 was identified in
sigmaA-weighted difference Fourier maps (with coefficients mjFoCa2+j-
DjFcmodel  Ca2+j and phases calculated by using a protein/solvent model with
no calcium atoms) as a very strong positive electron density peak (35.1 s) at
the hypervariable surface consistent with a Ca2+ ion bound with octahedral
geometry (2.43 A˚ from Asp772 [Od2], 2.31 A˚ and 2.30 A˚ from the backbone
carbonyl oxygens of residues Leu789 and Arg848, surrounded by three positive
solvent peaks at 2.40 A˚, 2.34 A˚, and 2.42 A˚ distance, respectively). However,
further inspection of the electron density indicated that the Ca2+-binding site is
partially occupied by the NH3
+/NH2 group of a Tris molecule. Refinement with
a Tris molecule alone at the Ca2+-binding site yielded a residual positive peak
in the mjFoj-DjFcj difference Fourier map of 17 s, while refinement of solely
a Ca2+ ion at this site yielded a negative peak of 12.5 s, both results indicat-
ing that the Ca2+-ion occupancy is less than 1.0 (Figures S1A and S1B). High
resolution structures of n1a_L4 at 1.4 A˚ derived from crystals soaked in Er3+ or
Sr2+ (Rmerge 4.5%, 96.6% complete, 7.33 multiple, and Rmerge 5.9%, 97.2%
complete, and 8.63 multiple, respectively, data further not presented)
revealed exceptionally high quality density for a Tris molecule bound at the
Ca2+-binding site and no evidence of any metal ion bound (shown for Er3+-
soaked crystals in Figure S1C).
Isothermal Titration Calorimetry
In preparation for isothermal titration calorimetry (ITC), protein was rendered
metal free by size-exclusion chromatography in 10 mM PIPES (pH 8),
100 mM NaCl, 5 mM EDTA and subsequently exhaustively buffer exchanged
into CHELEX-treated buffer (10 mMHEPES [pH 8], 100 mMNaCl) prior to con-
centration to 8.5 or 9.7 mg/ml (0.35 mM) for n1b and n1b+SS#4, respectively.
The proteins n1a_L4 and n1a_L4(10) required acidic conditions (pH% 6.5) for
solubility at 0.3 mM, conditions that could potentially lower Ca2+-binding affin-
ity. To improve solubility therefore and perform titrations under the same
conditions as n1b and n1b+SS#4, we produced metal-free GST-n1a_L4 and
GST-n1a_L4(10) fusions proteins with the method above, buffer exchanging
the proteins into CHELEX-treated buffer (10 mM HEPES [pH 8], 100 mM
NaCl) and concentrating them to 16.3 and 16.7 mg/ml, respectively
(0.35 mM), in preparation for ITC. To verify our decalcification procedure, we
decalcified bovine a-lactalbumin (Sigma), which has a single Ca2+-binding
site with approximately 20 nM affinity, and demonstrated Ca2+ binding by
using similar titration conditions as described in Griko and Remeta (1999).
ITC was carried out by using the procedures described in Sheckler et al.
(2006). N1b and n1b+SS#4 at a protein concentration of 0.35 mM in CHE-
LEX-treated buffer (10 mM HEPES [pH 8], 100 mM NaCl) were titrated with
8.1 mM CaCl2 at 5
C by using a Microcal VP-ITC in a series of 29 injections6, 422–431, March 2008 ª2008 Elsevier Ltd All rights reserved 429
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Neurexin LNS/LG Splice Isoformsor 40 injections of 5 ml, including a single 1 ml injection at the start of each titra-
tion. GST-n1a_L4 and GST-n1a_L4(10) at 0.35 mM protein concentration in
CHELEX-treated buffer (10 mM HEPES [pH 8], 100 mM NaCl) were titrated
with 6.0 mM CaCl2 at 5
C. For each protein, the heat of dilution was obtained
by carrying out a titration of Ca2+ directly into corresponding buffer (obtained
during the final concentration step). While the calorimetric data for n1b+SS#4
could be integrated in a semiautomatic fashion and fit to a single site, insuffi-
cient heat evolved per injection for an accurate binding isotherm to be derived
fromwhich estimates of K could be calculated. After each titration, sample was
extracted from the cell and centrifuged at 13,000 rpm, and the appearance of
a pellet investigated as a measure of protein precipitation. Very little precipita-
tion was observed for the different proteins after ITC runs, with the exception of
n1b+SS#4 where a small amount of precipitation were routinely observed,
further complicating attempts to extract an accurate binding constant from
the data. To check machine performance, before each series of titrations
a control ITC titration was performed with lysozyme (Sigma) and a ligand
N,N0,N00-Triacetylchitotriose (Sigma), which binds with a KD of approximately
4 mM (Cooper et al., 2001).
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